News

South Korean chemical giant LG Chem Ltd.'s offer for sale of its cosmetics filler business, tagged with an asking price of ...
The United States Naval Academy in Anapolis, Md., recently joined a growing list of schools that will no longer consider race, ethnicity or sex as a factor for admission, court documents made ...
This investment will support Tirupati's expansion plans and is likely to facilitate a complete exit for Affirma Capital, which had been a significant minority shareholder since its ₹350 crore ...
This strategic move provides a full exit to prior investor Affirma Capital, per the company's statement. Tirupati Medicare, founded in 2005, has emerged as a leading player in the nutraceutical ...
Kotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare, supporting the pharma company's expansion and marking Affirma Capital's exit. The investment focuses on Tirupati's ...
“At a stage where the business was growing at an unprecedented rate, we received strong support from Affirma Capital in setting up corporate governance and bringing in efficiencies in overall ...
This investment facilitates a complete exit of the existing investor Affirma Capital, besides supporting Tirupati’s expansion plans, a note on the development said. Founded in 2005, Tirupati ...
Emerging markets-focused private equity firm Affirma Capital has scored an exit from Tirupati Medicare Ltd as part of a transaction that involves Kotak Alternate Asset Managers Ltd investing in the ...
Kotak Alternate Asset Managers Limited (KAAML) has bought Affirma Capital’s stake in nutraceuticals contract manufacturer Tirupati Medicare for Rs 1,050 crore ($122.6 million), giving the ...
Private equity firm Affirma Capital which invests in emerging markets including South Korea, India, Southeast Asia, China, Africa and the Middle East, has pulled out more money from an India portfolio ...